Only Excedrin Brings Digital Pet Nostalgia Back with a Headache You Can't Ignore

Impact · against what's priced in

Haleon's launch of a caffeine-free and aspirin-free Excedrin Rapid Relief variant expands its addressable market to patients who avoid stimulants or aspirin. The accompanying 'My Little Headache' campaign leverages Y2K nostalgia to lower acquisition costs among younger demographics, providing a modest near-term catalyst for the OTC segment.

HLN+0.40

No priced-in read yet

In context

The introduction of an aspirin-free and caffeine-free formula allows Excedrin to target a broader patient demographic, while the Jesse McCartney-led digital campaign targets Gen Z and Millennial consumers to reduce acquisition costs.

Read from the article alone

• marketing campaignNew
• healthcare
• pharmaceuticals
• HLN
• consumer goods
• pain relief
• product launch

Top 1 mover · tap to explore